#BEGIN_DRUGCARD DB01851

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
2052-49-5

# ChEBI_ID:
45825

# Chemical_Formula:
C16H36N

# Chemical_IUPAC_Name:
tetrabutylazanium

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Detergents

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Tetrabutylammonium Ion

# HET_ID:
TBA

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C16H36N/c1-5-9-13-17(14-10-6-2,15-11-7-3)16-12-8-4/h5-16H2,1-4H3/q+1

# InChI_Key:
InChIKey=DZLFLBLQUQXARW-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1851

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
242.4637

# Molecular_Weight_Mono:
242.284775157

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1JVM

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
3.54

# Predicted_LogS:
-7.4

# Predicted_Water_Solubility:
1.14e-05 g/l

# Primary_Accession_No:
DB01851

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
16028

# PubChem_Substance_ID:
46507097

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT03013

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CCCC[N+](CCCC)(CCCC)CCCC

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:33 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cell membrane
multi-pass membrane protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Z37969

# Drug_Target_1_GenBank_ID_Protein:
1089906

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
kcsA

# Drug_Target_1_Gene_Sequence:
>483 bp
ATGCCACCCATGCTGTCCGGTCTTCTGGCCAGATTGGTCAAACTGCTGCTCGGGCGCCAC
GGCAGTGCGCTGCACTGGAGGGCCGCGGGTGCCGCGACGGTCCTCCTGGTGATCGTCCTC
CTCGCGGGCTCGTACTTGGCCGTCCTGGCTGAGCGCGGCGCACCGGGCGCGCAGCTGATC
ACGTATCCGCGGGCGCTGTGGTGGTCCGTGGAGACCGCGACGACCGTCGGCTACGGCGAC
CTGTACCCCGTGACTCTGTGGGGCCGGCTCGTGGCCGTGGTGGTGATGGTCGCCGGGATC
ACCTCCTTCGGTCTGGTGACCGCCGCGCTGGCCACCTGGTTCGTCGGCCGGGAACAAGAG
CGCCGGGGCCACTTCGTGCGCCACTCCGAGAAGGCCGCCGAGGAGGCGTACACGCGGACG
ACCCGGGCGCTGCACGAGCGTTTCGACCGTTTGGAGCGAATGCTCGACGACAACCGCCGG
TGA

# Drug_Target_1_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_1_General_References:
10757971	le Coutre J, Whitelegge JP, Gross A, Turk E, Wright EM, Kaback HR, Faull KF: Proteomics on full-length membrane proteins using mass spectrometry. Biochemistry. 2000 Apr 18;39(15):4237-42.
11158168	Cortes DM, Cuello LG, Perozo E: Molecular architecture of full-length KcsA: role of cytoplasmic domains in ion permeation and activation gating. J Gen Physiol. 2001 Feb;117(2):165-80.
11573095	Liu YS, Sompornpisut P, Perozo E: Structure of the KcsA channel intracellular gate in the open state. Nat Struct Biol. 2001 Oct;8(10):883-7.
11689935	Morais-Cabral JH, Zhou Y, MacKinnon R: Energetic optimization of ion conduction rate by the K+ selectivity filter. Nature. 2001 Nov 1;414(6859):37-42.
11689936	Zhou Y, Morais-Cabral JH, Kaufman A, MacKinnon R: Chemistry of ion coordination and hydration revealed by a K+ channel-Fab complex at 2.0 A resolution. Nature. 2001 Nov 1;414(6859):43-8.
7489706	Schrempf H, Schmidt O, Kummerlen R, Hinnah S, Muller D, Betzler M, Steinkamp T, Wagner R: A prokaryotic potassium ion channel with two predicted transmembrane segments from Streptomyces lividans. EMBO J. 1995 Nov 1;14(21):5170-8.
9525859	Doyle DA, Morais Cabral J, Pfuetzner RA, Kuo A, Gulbis JM, Cohen SL, Chait BT, MacKinnon R: The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science. 1998 Apr 3;280(5360):69-77.
9782060	Gouaux E: Single potassium ion seeks open channel for transmembrane travels: tales from the KcsA structure. Structure. 1998 Oct 15;6(10):1221-6.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2472

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
17694

# Drug_Target_1_Name:
Voltage-gated potassium channel

# Drug_Target_1_Number_of_Residues:
160

# Drug_Target_1_PDB_ID:
1F6G

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF07885	Ion_trans_2

# Drug_Target_1_Protein_Sequence:
>Voltage-gated potassium channel
MPPMLSGLLARLVKLLLGRHGSALHWRAAGAATVLLVIVLLAGSYLAVLAERGAPGAQLI
TYPRALWWSVETATTVGYGDLYPVTLWGRLVAVVVMVAGITSFGLVTAALATWFVGREQE
RRGHFVRHSEKAAEEAYTRTTRALHERFDRLERMLDDNRR

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Acts as a potassium ion channel

# Drug_Target_1_SwissProt_ID:
P0A334

# Drug_Target_1_SwissProt_Name:
KCSA_STRLI

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
10.66

# Drug_Target_1_Transmembrane_Regions:
28-50
88-111

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
2

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
J00241

# Drug_Target_2_GenBank_ID_Protein:
185945

# Drug_Target_2_GeneCard_ID:
IGKC

# Drug_Target_2_Gene_Name:
IGKC

# Drug_Target_2_Gene_Sequence:
Not Available

# Drug_Target_2_General_Function:
Involved in antigen binding

# Drug_Target_2_General_References:
4893682	Titani K, Shinoda T, Putnam FW: The amino acid sequence of a kappa type Bence-Jones protein. 3. The complete sequence and the location of the disulfide bridges. J Biol Chem. 1969 Jul 10;244(13):3550-60.
4923144	Gall WE, Edelman GM: The covalent structure of a human gamma G-immunoglobulin. X. Intrachain disulfide bonds. Biochemistry. 1970 Aug 4;9(16):3188-96.
5027703	Suter L, Barnikol HU, Watanabe S, Hilschmann N: [Rule of antibody structure. The primary structure of a monoclonal immunoglobulin L-chain of kappa-type, subgroup 3 (Bence-Jones protein Ti). IV. The complete amino acid sequence and its significance for the mechanism of antibody production] Hoppe Seylers Z Physiol Chem. 1972 Feb;353(2):189-208.
5447531	Kohler H, Shimizu A, Paul C, Putnam FW: Macroglobulin structure: variable sequence of light and heavy chains. Science. 1970 Jul 3;169(940):56-9.
5489770	Gottlieb PD, Cunningham BA, Rutishauser U, Edelman GM: The covalent structure of a human gamma G-immunoglobulin. VI. Amino acid sequence of the light chain. Biochemistry. 1970 Aug 4;9(16):3155-61.
5586923	Hilschmann N: [The complete amino acid sequence of Bence Jones protein Cum (kappa-type)] Hoppe Seylers Z Physiol Chem. 1967 Dec;348(12):1718-22.
6775818	Hieter PA, Max EE, Seidman JG, Maizel JV Jr, Leder P: Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments. Cell. 1980 Nov;22(1 Pt 1):197-207.
9588180	Olsen KE, Sletten K, Westermark P: Extended analysis of AL-amyloid protein from abdominal wall subcutaneous fat biopsy: kappa IV immunoglobulin light chain. Biochem Biophys Res Commun. 1998 Apr 28;245(3):713-6.

# Drug_Target_2_HGNC_ID:
GNC:5716

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
6338

# Drug_Target_2_Locus:
2p12

# Drug_Target_2_Molecular_Weight:
11608.8

# Drug_Target_2_Name:
Ig kappa chain C region

# Drug_Target_2_Number_of_Residues:
106

# Drug_Target_2_PDB_ID:
1N8Z

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF07654	C1-set

# Drug_Target_2_Protein_Sequence:
>Ig kappa chain C region
TVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDS
KDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
P01834

# Drug_Target_2_SwissProt_Name:
IGKC_HUMAN

# Drug_Target_2_Synonyms:
Not Available

# Drug_Target_2_Theoretical_pI:
5.68

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB01851
